IPO YEAR:
2020
|
Sector:
Health Care
|
Industry:
Biotechnology: Biological Products (No Diagnostic Substances)
|
ADRTSO:
|
MarketCap:
27130656.00
|
Beta:
0.548796569906870
|
52 Week High:
18.78
|
52 Week Low:
1.91
|
52 Week Change:
-0.8741092636579573
|
Short Interest:
|
Short Date:
|
Shares Outstanding:
35814255
|
Dividend Rate:
0
|
Dividend Yield:
N/A
|
ExDividend Date:
|
Latest EPS:
|
Latest EPS Date:
9 Nov 2022
|
Float:
0
|
return on Equity:
-163.40%
|
Consensus EPS:
|
Number Of Estimates:
|
EPS Surprise Dollar:
|
Eps Surprise Percent:
|
EBITDA:
N/A
|
ttmEPS:
0
|
Revenue:
$143.994M
|
Gross Profit:
|
Cash:
|
Debt:
|
Institution Percent:
82.10%
|
Revenue Percent:
|
Revenue Per Employee:
|
Insider Percent:
5.70%
|
Return on Assets:
-45.70%
|
Return on Capital:
|
Profit Margin:
-49.90%
|
Price to Sales:
9.46
|
Price To Book:
81.38
|
Short Ratio:
10.73
|
PE Ratio:
0
|
Employees:
2020
|
1Y Guesstimate
N/A:N/A:N/A
|
|
|
|
|
|
|
|
|
